Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × avelumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Merkel Cell 6 Urinary Bladder Neoplasms 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Carcinoma, Transitional Cell 3 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Penile Squamous Cell Carcinoma (PSCC) 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasm, Residual 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphatic Metastasis 1 Gallbladder Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 10 1

Interventions

tislelizumab 1 pembrolizumab 1 pegaspargase 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Vorinostat 1 Transplantation 1 Tacrolimus 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Methylprednisolone 1 Etoposide 1 Cyclophosphamide 1 Busulfan 1 Azacitidine 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡